| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-12 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |